Rhodobacter sphaeroides diphosphoryl lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal ST2 cells stimulated with lipopolysaccharide or paclitaxel (taxol)

Journal of Endotoxin Research

Volumn 4, Issue 2, 1997, Pages 115-122

  Kirikae, T ^a   Kirikae, F ^a   Tominaga, K ^a   Qureshi, N ^b   Yamamoto, S ^c   Nakano, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 6; LIPID A; PACLITAXEL;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL STIMULATION; COMPETITIVE INHIBITION; COMPLEX FORMATION; ENDOTHELIUM CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; RHODOBACTER SPHAEROIDES; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL;

EID: 0030913249     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400205     Document Type: Article

References (56)

1. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.
2. Raetz C.R.H., Ulevitch R.J., Wright S.D., Sibley C.H., Ding A., Nathan C.F. Gram-negative endotoxin: an extraordinaly lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5: 2652-2660.
3. Rietschel E.T., Brade H. Bacterial endotoxins. Sci Am 1992; 267: 54-61.
4. Rietschel E.T., Kirikae T., Schade F.U. et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-225.
5. Wright S.D., Jong M.C. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med 1986; 164: 1876-1888.
6. Hampton R.Y., Golenbock D.T., Marsha P., Krieger M., Raetz C.R.H. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991; 352: 342-344.
7. Lei M.-G., Morrison D.C. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol 1988; 141: 996-1005.
8. Kirikae T., Kirikae F., Schade F.U. et al. Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophages-like cell lines. FEMS Microbiol Immunol 1991; 76: 327-336.
9. Schumann R.R., Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
10. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
11. Ding A.H., Porteu F., Sanchez E., Nathan C.F. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 1990; 248: 370-372.
12. Manthey C.L., Vogel S.N. Taxol: a promising endotoxin research tool. J Endotoxin Res 1994; 1: 189-198.
13. Pazdur R., Kudelka A.P., Kavanagh J.J., Cohen P.R., Raber M.N. The taxoids: paclitaxel (taxol) and docetaxel (taxotere). Cancer Treat Rev 1993; 19: 351-386.
14. Kirikae F., Kirikae T., Qureshi N., Takayama K., Morrison D.C., Nakano, M. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 1995; 63: 486-497.
15. Bogdan C., Ding A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor a and interleukin-1 in macrophages. J Leukoc Biol 1992; 52: 119-121.
16. Lynn W.A., Golenbock D.T. Lipopolysaccharide antagonists. Immunol Today 1992; 13: 271-276.
17. Takayama K., Qureshi N., Beutler B., Kirland T.N. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect Immun 1989; 57: 1336-1338.
18. Strittmatter W., Weckesser J., Salimath P.V., Galanos C. Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol 1983; 155: 153-158.
19. Qureshi N., Honovich J.P., Hara H., Cotter R.J., Takayama K. Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem 1988; 263: 5502-5504.
20. Qureshi N., Takayama K., Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991; 59: 441-444.
21. Qureshi N., Takayama K., Meyers K.C. et al. Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodopseudomonas sphaeroides. Comparison of biological properties before and after reduction. J Biol Chem 1991; 266: 6532-6538.
22. Henrickson B.E., Perera P.Y., Qureshi N., Takayama K., Vogel S.N. Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A. Infect Immun 1992; 60: 4285-4290.
23. Kirikae T., Schade F.U., Kirikae F., Qureshi N., Takayama K., Rietschel E.T. Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol Med Microbiol 1994; 9: 237-244.
24. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R.H. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.
25. Salimath P.V., Weckesser J., Strittmatter W., Mayer H. Structural studies on the non-toxic lipid A from Rhodopseudomonas sphaeroides ATCC 17023. Eur J Biochem 1983; 136: 195-200.
26. Pugin J., Schurer-Maly C-C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-2748.
27. Haziot A., Rong G-W., Silver J., Goyert S.M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 1993; 151: 1500-1507.
28. Loppnow H., Stelter F., Schönbeck U. et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995; 63: 1020-1026.
29. Patrick D., Betts J., Frey E.A., Prameya R., Dorovini-Zis K., Finlay B.B. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cell via a serum-dependent cytotoxic pathway. J Infect Dis 1992; 165: 865-872.
30. Frey E.A., Miller D.S., Jahr T.G. et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-1671.
31. Obayashi T., Tamura H., Tanaka S. et al. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985; 149: 55-65.
32. Kirikae T., Kirikae F., Oghiso Y., Nakano M. Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (taxol). Infect Immun 1996; 64: 3379-3384.
33. Setoguchi M., Nasu N., Yoshida S., Higuchi Y., Akizuki S., Yamamoto S. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta 1989; 1008: 213-222.
34. Van Snick J., Cayphas S., Szikora J.P. et al. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol 1988; 18: 193-197.
35. Nishikawa S.-I., Ogawa M., Nishikawa S., Kunisada T., Kodama H. B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol 1988; 18: 1767-1771.
36. Lansdorp P.M., Aarden L.A., Calafat J., Zeiljemaker W.P. A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986; 132: 105-113.
37. Kirikae T., Schade F.U., Zähringer U. et al. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. FEMS Immunol Med Microbiol 1994; 8: 13-26.
38. 15N]-nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
39. Ding A., Sanchez E., Nathan C.F. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol 1993; 151: 5596-5602.
40. Ding A., Chen B., Fuortes M., Blum E. Association of mitogen-activated protein kinases with microtubules in mouse macrophages. J Exp Med 1996; 183: 1899-1904.
41. Henricson B.E., Carboni J.M., Burkhardt A.L., Vogel S.N. LPS and taxol activate Lyn kinase autophosphorylation in Lps(n), but not in Lps(d), macrophages. Mol Med 1995; 1: 428-435.
42. Manthey C.L., Brandes M.E., Perera P.Y., Vogel S.N. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 1992; 149: 2459-2465.
43. Manthey C.L., Perera P.Y., Salkowski C.A., Vogel S.N. Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 1994; 152: 825-831.
44. Perera P.Y., Qureshi N., Vogel S.N. Paclitaxel (taxol)-induced NF-κB translocation in murine macrophages. Infect Immun 1996; 64: 878-884.
45. Manthey C.L., Qureshi N., Stutz P.L., Vogel S.N. Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J Exp Med 1993; 178: 695-702.
46. Nasu N., Yoshida S., Akizuki S., Higuchi Y., Setoguchi M., Yamamoto S. Molecular and physiological properties of murine CD14. Int Immunol 1991; 3: 205-213.
47. Goyert S.M., Ferrero E., Rettig W.J., Yenamanda A.K., Obata F., LeBeau M.M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497-500.
48. Haziot A., Chen S., Ferrero E., Low M.G., Silver J., Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyl-inositol linkage. J Immunol 1988; 141: 547-552.
49. Kirikae T., Schade F.U., Kirikae F., Rietchel E.T., Morrison D.C. Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide. Influence of serum and lipopolysaccharide chain length on macrophage activation. J Immunol 1993; 151: 2742-2752.
50. Ding A., Sanchez E., Tancinco M., Nathan C. Interactions of bacterial lipopolysaccharide with microtubule proteins. J Immunol 1992; 148: 2853-2858.
51. Parness J., Horwit S.B. Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981; 91: 479-487.
52. Rao S., Krauss E., Heerding J.M. et al. 3′-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J Biol Chem 1994; 269: 3132-3134.
53. Nogales E., Wolf S.G., Khan I.A., Ludueña R.F., Dowing K.H. Structure of tubulin at 6.5 Å and location of the taxol-binding site. Nature 1995; 375: 424-427.
54. Kirikae T., Ojima I., Kirikae F. et al. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem Biophys Res Commun 1996; 227: 227-235.
55. Delude R.L., Savedra J.R., Zhao H. et al. CD14 enhances cellular responses to endotoxin with imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995; 92: 9288-9292.
56. Lei M-G., Qureshi N., Morrison D.C. Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A. Immunol Lett 1993; 36: 245-250.